静脉注射设备市场 - 全球产业规模、份额、趋势、机会和预测、细分类型、按最终用户、按地区和竞争，2020-2030 年预测

2024 年全球静脉 (IV) 设备市场价值为 135.7 亿美元，预计在预测期内将实现强劲增长，到 2030 年的复合年增长率为 5.27%。全球静脉 (IV) 设备市场是更广泛的医疗保健行业中一个充满活力且快速发展的行业，在患者护理和治疗中发挥关键作用。静脉治疗包括透过静脉将液体、药物和营养物质直接注入血液，相应的设备包括各种旨在促进此过程的设备。随着全球慢性病发病率不断上升、人口老化以及外科手术数量的不断增加，市场对创新和先进的静脉注射设备的需求不断增长。例如，根据世界卫生组织2021年4月发布的资料，慢性病预计每年导致4,100万人死亡，占全球死亡人数的71%。此外，中低收入国家 77% 的死亡是由慢性病造成的。随着癌症病例和其他慢性病数量的增加，对各种外科手术的需求预计将增加，从而推动市场成长。

推动全球静脉注射设备市场成长的关键因素包括糖尿病、癌症和心血管疾病等疾病发生率的不断上升，需要高效、精确的药物传递机制。随着全球医疗保健系统专注于改善患者治疗效果和减少住院时间，静脉治疗的需求激增。智慧型帮浦、安全输液系统和无线连接等静脉注射设备的技术进步提高了药物管理的准确性和安全性，进一步推动了市场扩张。

主要市场驱动因素

慢性病盛行率上升

主要市场挑战

成本限制和可负担性

主要市场趋势

注重以病人为中心的医疗保健

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球静脉注射（IV）设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依类型（静脉导管、输液帮浦、固定装置、给药装置、滴注器、其他类型）
  • 按最终使用者（医院、门诊手术中心、其他最终使用者）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 按最终用户
  • 按地区

第 5 章：亚太地区静脉注射（IV）设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型
  • 按最终用户
  • 按国家
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第 6 章：欧洲静脉注射（IV）设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美静脉注射（IV）设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 墨西哥
  • 加拿大

第八章：南美洲静脉注射（IV）设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲静脉注射（IV）设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 埃及

第十章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 12 章：全球静脉注射 (IV) 设备市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• 3D Systems, Inc.
• 3M Company
• Baxter International
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• EuroLife Healthcare Pvt. Ltd
• Henry Schein, Inc
• ICU Medical, Inc
• Polymedicure
• Terumo Corporation
• Teleflex Incorporated

第 15 章：策略建议

第16章调查会社について・免责事项

Global Intravenous (IV) Equipment Market was valued at USD 13.57 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.27% through 2030. The Global Intravenous (IV) Equipment Market is a dynamic and rapidly evolving sector within the broader healthcare industry, playing a pivotal role in patient care and treatment. Intravenous therapy involves the administration of fluids, medications, and nutrients directly into the bloodstream through a vein, and the corresponding equipment encompasses a wide range of devices designed to facilitate this process. The market is characterized by a growing demand for innovative and advanced IV equipment, driven by the increasing prevalence of chronic diseases, the aging population, and the rising number of surgical procedures globally. For instance, according to data from the World Health Organization published in April 2021, chronic diseases are projected to cause 41 million deaths annually, accounting for 71% of all global deaths. Additionally, 77% of mortality in low- and middle-income countries is attributed to chronic diseases. As the number of cancer cases and other chronic conditions rise, the demand for various surgical procedures is expected to increase, driving market growth.

Key factors contributing to the growth of the Global Intravenous Equipment Market include the escalating incidence of diseases such as diabetes, cancer, and cardiovascular disorders, necessitating efficient and precise drug delivery mechanisms. As healthcare systems worldwide focus on improving patient outcomes and minimizing hospital stays, the demand for intravenous therapies has surged. The technological advancements in IV equipment, such as smart pumps, safety infusion systems, and wireless connectivity, have enhanced the accuracy and safety of drug administration, further fueling market expansion.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a pivotal factor driving the robust growth of the Global Intravenous (IV) Equipment Market. Chronic diseases, including diabetes, cardiovascular disorders, and cancer, have witnessed a significant surge in incidence worldwide. These conditions often necessitate long-term and intricate medical interventions, with intravenous therapy emerging as a crucial component of their management. The prevalence of chronic diseases is influenced by factors such as sedentary lifestyles, aging populations, and changes in dietary habits. As a result, there is an escalating demand for advanced and efficient intravenous solutions and equipment to facilitate the administration of medications and fluids required for the treatment of chronic conditions. For instance, according to the Alzheimer Society of Canada, over 500,000 Canadians were living with dementia as of January 2021, with the number expected to increase to 912,000 by 2030. Similarly, the Fondation de France reported that around 150,000 people in France were affected by Parkinson's disease in 2021, with the disease predominantly impacting the elderly. As the prevalence of chronic diseases rises, the demand for related healthcare solutions is expected to drive market growth in the coming years.

Key Market Challenges

Cost Constraints and Affordability

Cost constraints and affordability represent significant hurdles for the Global Intravenous (IV) Equipment Market, posing challenges to the widespread adoption of advanced intravenous technologies. The intricate and innovative nature of modern IV equipment, including infusion pumps, smart catheters, and monitoring systems, often comes with a hefty price tag. This presents a barrier for healthcare facilities, particularly in resource-limited regions, where financial constraints impede the seamless integration of state-of-the-art IV solutions.

One of the primary obstacles is the high initial investment required for acquiring advanced IV equipment. Hospitals and healthcare providers, particularly those in developing countries, often operate on tight budgets, making it challenging to allocate substantial funds for the purchase of cutting-edge IV technologies. The upfront costs for these devices can strain financial resources, limiting the ability of healthcare facilities to invest in the latest innovations that could otherwise enhance patient care and safety.

Key Market Trends

Focus on Patient-Centric Healthcare

The Global Intravenous (IV) Equipment Market is experiencing a significant boost due to a pronounced shift towards patient-centric healthcare. This transformative trend places the patient at the center of the healthcare experience, influencing the design, functionality, and adoption of intravenous equipment. Recognizing the importance of patient comfort and adherence to treatment plans, manufacturers are increasingly prioritizing user-friendly features in the development of IV devices. Catheters, infusion pumps, and related accessories are being designed with a focus on minimizing discomfort, simplifying usage, and reducing the risk of complications.

Key Market Players

• 3D Systems, Inc.
• 3M Company
• Baxter International
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• EuroLife Healthcare Pvt. Ltd
• Henry Schein, Inc
• ICU Medical, Inc
• Polymedicure
• Terumo Corporation
• Teleflex Incorporated

Report Scope:

In this report, the Global Intravenous (IV) Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intravenous (IV) Equipment Market, By Type:

• IV Catheters
• Infusion Pumps
• Securement Devices
• Administration Sets
• Drip Chambers
• Other Types

Intravenous (IV) Equipment Market, By End User:

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

Intravenous (IV) Equipment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intravenous (IV) Equipment Market.

Available Customizations:

Global Intravenous (IV) Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Intravenous (IV) Equipment Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (IV Catheters, Infusion Pumps, Securement Devices, Administration Sets, Drip Chambers, Other Types)
  • 4.2.2. By End-User (Hospitals, Ambulatory Surgical Centers, Other End-Users)
  • 4.2.3. By Region
  • 4.2.4. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By End-User
  • 4.3.3. By Region

5. Asia Pacific Intravenous (IV) Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By End-User
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Intravenous (IV) Equipment Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By End-User
  • 5.3.2. India Intravenous (IV) Equipment Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By End-User
  • 5.3.3. Australia Intravenous (IV) Equipment Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By End-User
  • 5.3.4. Japan Intravenous (IV) Equipment Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By End-User
  • 5.3.5. South Korea Intravenous (IV) Equipment Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By End-User

6. Europe Intravenous (IV) Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Intravenous (IV) Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End-User
  • 6.3.2. Germany Intravenous (IV) Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End-User
  • 6.3.3. Spain Intravenous (IV) Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End-User
  • 6.3.4. Italy Intravenous (IV) Equipment Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By End-User
  • 6.3.5. United Kingdom Intravenous (IV) Equipment Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By End-User

7. North America Intravenous (IV) Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Intravenous (IV) Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End-User
  • 7.3.2. Mexico Intravenous (IV) Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End-User
  • 7.3.3. Canada Intravenous (IV) Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End-User

8. South America Intravenous (IV) Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Intravenous (IV) Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End-User
  • 8.3.2. Argentina Intravenous (IV) Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End-User
  • 8.3.3. Colombia Intravenous (IV) Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End-User

9. Middle East and Africa Intravenous (IV) Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Intravenous (IV) Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End-User
  • 9.3.2. Saudi Arabia Intravenous (IV) Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End-User
  • 9.3.3. UAE Intravenous (IV) Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End-User
  • 9.3.4. Egypt Intravenous (IV) Equipment Market Outlook
    • 9.3.4.1. Market Size & Forecast
      • 9.3.4.1.1. By Value
    • 9.3.4.2. Market Share & Forecast
      • 9.3.4.2.1. By Type
      • 9.3.4.2.2. By End-User

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Intravenous (IV) Equipment Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. 3D Systems, Inc.
  • 14.1.1. Company Snapshot
  • 14.1.2. Products & Services
  • 14.1.3. Current Capacity Analysis
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. 3M Company
• 14.3. Baxter International
• 14.4. Becton, Dickinson and Company
• 14.5. B. Braun Melsungen AG
• 14.6. EuroLife Healthcare Pvt. Ltd
• 14.7. Henry Schein, Inc
• 14.8. ICU Medical, Inc
• 14.9. Polymedicure
• 14.10.Terumo Corporation
• 14.11.Teleflex Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer